Tender Results of The Common Services Agency More Commonly Known As Nhs National Services Scotland

NP34925c Anti Rabies immunoglobulin intramuscular use (IM)-Supply of Anti Rabies immunoglobulin intramuscular use (IM) to NHS Scotland. The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the twenty-four (24) month Framework Agreement duration and the twenty-four (24) month extension period of the Framework Agreement. (SC Ref:797781)

NP34925a Hepatitis B immunoglobulin intramuscular use (IM)-The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the twenty-four (24) month Framework Agreement duration and the twenty-four (24) month extension period of the Framework Agreement. (SC Ref:797764) Supply of Hepatitis B immunoglobulin intramuscular use (IM) to NHS Scotland.

NP48925c Hereditary Angioedema Branded Medicines (Ruconest)-Supply of conestat alfa 2,100unit powder for solution for injection vials (Ruconest®) to NHS Scotland: The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the twenty-four (24) month Framework Agreement duration and the twenty-four (24) month extension period of the Framework Agreement. Details of individual lines awarded can be requested from the named person at the head of this notice. (SC Ref:797709)

NP47825 Multiple Sclerosis Medicines-The estimated values referred to in Section II.1.7 and Section V.2.4 and within all Lots cover the twenty-seven (27) month contract duration and the twenty-one (21) month extension period of the Framework Agreement. (SC Ref:797683) Supply of multiple sclerosis medicines to NHS Scotland.

NP48925c Hereditary Angioedema Branded Medicines (Ruconest)-The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the twenty-four (24) month Framework Agreement duration and the twenty-four (24) month extension period of the Framework Agreement. Details of individual lines awarded can be requested from the named person at the head of this notice. (SC Ref:797709) Supply of conestat alfa 2,100unit powder for solution for injection vials (Ruconest®) to NHS Scotland:

NP34925b Tetanus immunoglobulin intramuscular use (IM)-Supply of Tetanus immunoglobulin intramuscular use (IM) to NHS Scotland. The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the twenty-four (24) month Framework Agreement duration and the twenty-four (24) month extension period of the Framework Agreement. (SC Ref:797778)

NP34925b Tetanus immunoglobulin intramuscular use (IM)-The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the twenty-four (24) month Framework Agreement duration and the twenty-four (24) month extension period of the Framework Agreement. (SC Ref:797778) Supply of Tetanus immunoglobulin intramuscular use (IM) to NHS Scotland.

NP48925b Hereditary Angioedema Branded Medicines (Berinert)-The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the twenty-four (24) month Framework Agreement duration and the twenty-four (24) month extension period of the Framework Agreement. Details of individual lines awarded can be requested from the named person at the head of this notice. (SC Ref:797706) Supply of C1-esterase inhibitor human powder and solvent for solution for injection vials (various strengths) (Berinert®) to NHS Scotland.

NP47825 Multiple Sclerosis Medicines-Supply of multiple sclerosis medicines to NHS Scotland. The estimated values referred to in Section II.1.7 and Section V.2.4 and within all Lots cover the twenty-seven (27) month contract duration and the twenty-one (21) month extension period of the Framework Agreement. (SC Ref:797683)

NP34925g Anti-human T lymphocyte immunoglobulin (equine)-The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the twenty-four (24) month Framework Agreement duration and the twenty-four (24) month extension period of the Framework Agreement. (SC Ref:797782) Supply of Anti-human T lymphocyte immunoglobulin (equine) to NHS Scotland.